Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HLA-DRA anticorps

Cet anticorps anti-HLA-DRA est un anticorps Souris Monoclonal détectant HLA-DRA dans FACS, IF et IHC (f). Adapté pour Humain.
N° du produit ABIN6937414

Aperçu rapide pour HLA-DRA anticorps (ABIN6937414)

Antigène

Voir toutes HLA-DRA Anticorps
HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Reactivité

  • 97
  • 17
  • 10
  • 9
  • 9
  • 9
  • 4
  • 3
  • 3
  • 1
Humain

Hôte

  • 62
  • 49
  • 4
  • 1
  • 1
Souris

Clonalité

  • 67
  • 50
Monoclonal

Conjugué

  • 59
  • 12
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Cet anticorp HLA-DRA est non-conjugé

Application

  • 55
  • 52
  • 40
  • 34
  • 19
  • 16
  • 13
  • 9
  • 9
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

19-26-1-same as MB-26-1
  • Specificité

    This MAb reacts with the HLA-DR antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Raji cells

    Isotype

    IgG2a kappa
  • Indications d'application

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: Raji, Ramos, Daudi or HuT78 cells. Tonsil or lymph node.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    HLA-DRA (HLA Class II DR alpha (HLA-DRA))

    Autre désignation

    HLA-DRA

    Sujet

    DR alpha chain, HLA class II histocompatibility antigen, HLA class II histocompatibility antigen DR alpha chain, HLA DRA, HLA DRA1, HLA-DRA, HLADRA1, Major histocompatibility complex class II DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA,HLA-DRA (MHC II)
    Cellular localisation: Cell surface

    Poids moléculaire

    36kDa (α, chain) and 27kDa (β, chain)

    ID gène

    3122, 520048

    UniProt

    P01903

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Vous êtes ici:
Chat with us!